A GlP 1 analog improves the prognosis of type 2 diabetes with and without vascular disease. The ReWinD trial

pp 324-331

Authors

  • Jorge Thierer

DOI:

https://doi.org/10.7775/rac.es.v87.i4.15889

Abstract

  

 

 

Published

2025-05-07

Issue

Section

OUTSTANDING PUBLICACIONES

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>